Evaluation on PCOS in Hypothyroidism among Young Females in the Age Group of 18-25 Years: A Study from Tamilnadu, India

Dr. R. Anusha; Dr. P. Allwin Christuraj; U. Sudhaveni; H. Nasiya; E. Esakki Karthick1

1

Publication Date: 2024/08/12

Abstract: A multifactorial ailment, polycystic ovary syndrome, is typified by persistent anovulation along with indications of excess androgen without the presence of other particular diseases of the pituitary, thyroid, or adrenal glands that might cause comparable symptoms. Because polycystic ovarian syndrome is frequently accompanied by obesity, elevated insulin resistance and increased metabolic and cardiovascular risk factors are commonly linked to the condition. In Kulasekharam, Tamil Nadu, India, at the Sree Ramakrishna Medical College of Naturopathy and Yogic Sciences and Hospital, the study was conducted. Women who are between the ages of 18 and 25 are taking part in the research. After outlining the purpose of the study, verbal consent was obtained. This survey received 30 responses. There are thirty questions in the survey. The following subjects were included in the questionnaire's parameters: food, menstruation disorders, anxiety, hair care, and digestive problems. The study excluded female subjects who were unwilling or uncooperative. Most women are affected by polycystic ovarian syndrome. Their food is not well- balanced and healthy. Women also need to be better informed on the importance of maintaining good hygiene, eating a balanced diet, drinking enough water, and the dangers of junk food. They also need to learn more about gut dysbiosis and how to prevent exposure to environmental pollutants. Future medical treatments should concentrate on these areas in order to improve young women's general health and wellness.

Keywords: Stress, Anxiety, Menstrual Disorder, Polycystic Ovary Syndrome.

DOI: https://doi.org/10.38124/ijisrt/IJISRT24JUL1405

PDF: https://ijirst.demo4.arinfotech.co/assets/upload/files/IJISRT24JUL1405.pdf

REFERENCES

  1. Uche Anadu Ndefo, Angie Eaton, Monica Robinson Green,A Review of Treatment Options With a Focus on Pharmacological Approaches,2013.
  2. Umland EM, Weinstein LC, Buchanan EM. Menstruation-related disorders. In: DiPiro JT, Talbert RL, Yee GC, et al., editors. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. New York: McGraw-Hill; 2011.
  3. Femara (letrozole), prescribing information. East Hanover, N.J.: Novartis; 2011.
  4. Samradhi Singh,Namrata Pal,Swasti Shubham,Devojit Kumar Sarma,Vinod Verma,Francesco Marotta,Manoj Kumar. Polycystic ovary syndrome: Etiology, current, management, and future therapeutics2023.
  5. dehghani Firouzabadi, R.; Aflatoonian, A.; Modarresi, S.; Sekhavat, L.; MohammadTaheri, S. Therapeutic effects of calcium & vitamin D supplementation in women with PCOS. Complement.2012.
  6. Cefalu, W.T. The physiologic role of incretin hormones: Clinical applications. J. Osteopath. Med. 2010.
  7. Qi, X.; Yun, C.; Sun, L.; Xia, J.; Wu, Q.; Wang, Y.; Wang, L.; Zhang, Y.; Liang, X.; Wang, L. Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome. J. Endocrinol. 2019.
  8. Recent advances in the management of polycystic ovary syndrome: A Review article, Shivani Akre, Kapil sharma chakole, and Mayur B Wanjari,2002.
  9. A review: Brief insight into polycystic ovarian syndrome. Bulsara J, Patel P, Soni A, et al.2021.
  10. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS),Sana Siddiqui, Somaiya Mateen, Rizwan Ahmad, and Shagufta Moin,2022.